The cerebellum plays a critical role in ensuring smooth, precise, and balanced movement. It helps coordinate muscle activity so that walking, running, and other motions occur in a controlled and stable manner. In dogs with HCA, damage or degeneration of cerebellar cells disrupts this coordination system, leading to progressively abnormal movement patterns.
Clinical signs of Hereditary Cerebellar Ataxia typically appear in young dogs or early adulthood, depending on breed and mutation severity. Early symptoms may include subtle unsteadiness, mild swaying while walking, or difficulty maintaining balance during movement. As the condition progresses, affected dogs develop more obvious neurological signs such as a wide-based stance, exaggerated limb movements (hypermetria), and frequent stumbling or falling.
Dogs with HCA may also have difficulty with tasks requiring precision, such as climbing stairs, jumping, or navigating uneven surfaces. Head tremors, especially during movement or when attempting to focus, may also be observed. Unlike muscular or joint disorders, the primary issue lies in the brain’s ability to coordinate movement rather than in the limbs themselves.
As HCA progresses, coordination continues to decline. Affected dogs may require assistance with mobility and may eventually become unable to walk without support. Despite these motor difficulties, cognitive function is often preserved, meaning dogs remain aware and responsive even as physical coordination worsens.
The HCA DNA Health Test is designed to detect the specific genetic mutation responsible for Hereditary Cerebellar Ataxia. The test is simple, safe, and non-invasive, typically performed using a cheek swab or blood sample. The collected DNA is analyzed in a specialized laboratory to determine whether the dog carries zero, one, or two copies of the mutation. Because DNA remains unchanged throughout life, testing can be performed at any age, including before clinical signs appear.
Results are generally reported as:
- Clear (Normal): The dog does not carry the HCA mutation and is not expected to develop or pass on the disease.
- Carrier: The dog carries one copy of the mutation but typically does not show clinical signs. However, it can pass the mutation to future generations.
- Affected/At Risk: The dog carries two copies of the mutation and is expected to develop progressive cerebellar dysfunction associated with HCA.
Genetic testing for HCA is highly valuable for breeders, veterinarians, and dog owners. Breeders can use results to avoid carrier-to-carrier matings, significantly reducing the incidence of this neurological disorder while maintaining healthy genetic diversity within the breed population.
For dog owners, knowing a dog’s genetic status allows for early monitoring and supportive care planning. While there is currently no cure for HCA, supportive management such as physiotherapy, controlled exercise, assistive mobility devices, and environmental modifications can help maintain quality of life for as long as possible. Regular neurological evaluations are important to track progression.
The Hereditary Cerebellar Ataxia (HCA) Health Test is a reliable genetic screening tool that supports responsible breeding practices, promotes canine neurological health, and helps reduce the impact of this inherited coordination disorder in future generations.
